Skip to main content

and
  1. Article

    Open Access

    LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2

    Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic val...

    **n Wang, Lalit Sehgal, Neeraj Jain, Tamer Khashab in Journal of Translational Medicine (2016)